Viral Vector gene therapy has been the focus of intense research driven by the safety profile and several clinical breakthroughs. As of March 2022, there are two viral vector gene therapies approved ...
What people say about this course: "This was perhaps the first course where really comprehensive and complete NGS information, from A to Z, was provided. A really well-done event we would be happy to ...
Charlotte, NC, United States, 21st Nov 2025 – X-Sense announced the introduction of a next-generation system designed to support household awareness of developing hazards. The announcement centers on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results